Journal of Allergy and Clinical Immunology
Chapter 8Asthma: Clinical expression and molecular mechanisms
Key words
Abbreviations used
Cited by (0)
Supported by National Institutes of Health grants 1P01HL70831-01, HL56396, and AI50500.
Disclosure of potential conflict of interest: R. F. Lemanske is a Speaker for Merck, Doembecher Children's Hospital, Washington University, Medicus Group, Park Nicolet Institute, ACAAI, LA Allergy Society, Michigan Allergy/Asthma Society, Medical College of Wisconsin, Fund for Medical Research and Education (Detroit), Children's Hospital of Minnesota, Toronto Allergy Society, AAAAI, Beaumont Hospital, University of Illinois, Canadian Society of Allergy and Clinical Immunology, and New York Presbyterian; is a consultant and speaker for AstraZeneca; is a consultant for Map Pharmaceuticals, Gray Consulting, Smith Research, Inc., Merck Childhood Asthma Network, Novartis, Quintiles/Innovax, RC Horowitz & Co, Inc., International Meetings and Science, and Scienomics; is an author for Up-to-Date; and is an Editor for Elsevier, Inc. W. W. Busse is on the Advisory Board for Altair, Amgen, Abbott Laboratories, Asthmatx, Bristol-Meyer Squibb, Centocor, Genentech, GlaxoSmithKline, Merck, Pfizer, Schering-Plough, and Wyeth; is a speaker for Merck, and a consultant for Alexion, AstraZeneca, Boehringer Ingelheim, Dainippon Sumitomo, Funxional Therapeutics Ltd, Novartis, and TEVA; and has received research support from Novartis, Centocor, GlaxoSmithKline, MedImmune, Ception, and the National Institutes of Health–National Institute of Allergy and Infectious Diseases, and the National Heart, Lung, and Blood Institute.